This scholarship is named in tribute to Kevin Child, who died of AIDS in 1989, shortly before graduating from college.
These symposia were designed to encompass critical topics with far reaching implications for our communities, including emerging and novel therapies, surveillance, and key public health-related issues relevant to affected women and girls.
86 percent of registered voters believe the government should require copay assistance to be applied to patients’ cost-sharing requirements
Thirty three organizations, including NHF, urge elected officals to ensure all people living in the US have access to adequate and affordable health coverage.
The purpose of the study is to evaluate the efficacy and safety of this investigational gene therapy in patients with moderately severe to severe hemophilia A.
On September 25, more than 300 people from across the country tuned in to this year’s virtual Red Tie Soiree.
Watch this moderated webinar regarding the current status of gene therapies in the pipeline and other novel therapies.
CSL Behring provided a statement to NHF and HFA regarding the recall of Stimate® (desmopressin) nasal spray.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car